Growth differentiating factor-9 mutations may be associated with premature ovarian failure

Fertility and Sterility

Volumn 87, Issue 1, 2007, Pages 143-146

  Kovanci, Ertug ^a   Rohozinski, Jan ^a   Simpson, Joe Leigh ^a   Heard, Michael J ^b   Bishop, Colin E ^a   Carson, Sandra A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Women's Specialists of Houston   (United States)

Author keywords

growth differentiating factor 9; mutation; Premature ovarian failure; single nucleotide polymorphism

Indexed keywords

CYTOSINE; GENOMIC DNA; GROWTH DIFFERENTIATION FACTOR 9; PROLINE; SERINE; THYMIDINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; EXON; FEMALE; GENE; GENE MUTATION; GENETICS; GROWTH DIFFERENTIATION FACTOR 9 GENE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OVARIAN FAILURE, PREMATURE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STATISTICS; UNITED STATES;

EID: 33845728499     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.05.079     Document Type: Article

References (19)

1. Coulam C.B., Adamson S.C., and Annegers J.F. Incidence of premature ovarian failure. Obstet Gynecol 67 (1986) 604-606
2. Simpson J.L., and Elias S. Genetics in obstetrics and gynecology. 3rd ed. (2003), W. B. Saunders, Philadelphia
3. Simpson J.L., and Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 89 (1999) 186-200
4. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., and Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383 (1996) 531-535
5. McNatty K.P., Moore L.G., Hudson N.L., Quirke L.D., Lawrence S.B., Reader K., et al. The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction 128 (2004) 379-386
6. Galloway S.M., McNatty K.P., Cambridge L.M., Laitinen M.P., Juengel J.L., Jokiranta T.S., et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25 (2000) 279-283
7. Di Pasquale E., Beck-Peccoz P., and Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75 (2004) 106-111
8. Liao W.X., Moore R.K., Otsuka F., and Shimasaki S. Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9: implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J Biol Chem 278 (2003) 3713-3719
9. Elvin J.A., Clark A.T., Wang P., Wolfman N.M., and Matzuk M.M. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 13 (1999) 1035-1048
10. Gui L.M., and Joyce I.M. RNA interference evidence that growth differentiation factor-9 mediates oocyte regulation of cumulus expansion in mice. Biol Reprod 72 (2005) 195-199
11. Juengel J.L., Hudson N.L., Heath D.A., Smith P., Reader K.L., Lawrence S.B., et al. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod 67 (2002) 1777-1789
12. Hanrahan J.P., Gregan S.M., Mulsant P., Mullen M., Davis G.H., Powell R., et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis Aries). Biol Reprod 70 (2004) 900-909
13. Dixit H., Rao L.K., Padmalatha V., Kanakavalli M., Deenadayal M., Gupta N., et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12 (2005) 749-754
14. O'Donovan M.C., Oefner P.J., Roberts S.C., Austin J., Hoogendoorn B., Guy C., et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 52 (1998) 44-49
15. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., and Donnelly P. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
16. Takebayashi K., Takakura K., Wang H., Kimura F., Kasahara K., and Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 74 (2000) 976-979
17. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8 (1994) 133-146
18. Liao W.X., Moore R.K., and Shimasaki S. Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem 279 (2004) 17391-17396
19. Laissue P., Christin-Maitre S., Touraine P., Kuttenn F., Ritvos O., Aittomaki K., Bourcigaux N., Jacquesson L., Bouchard P., Frydman R., Dewailly D., Reyss A.C., Jeffery L., Bachelot A., Massin N., Fellous M., and Veitia R.A. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian faulure. Eur J Endocrinol 154 (2006) 739-744